In accordance with the spirit of the provincial government special meeting,November 24,The provincial new coronavirus vaccine project team organized a new coronavirus vaccine project promotion meeting at Shunde Building。The meeting was chaired by Deputy Secretary of the Party Committee of Shandong Development Investment seabet.com、Presided over by General Manager Guo Xiaodong。Relevant leaders of the Provincial Department of Industry and Information Technology,Luxin seabet.com、Shandong Finance、Shandong SDIC、Shandong Guohui、Comrades in charge and heads of business departments of Shandong New Kinetic Energy and other provincial enterprises,and Luye Investment seabet.com、Yantai Guofeng seabet.com、Relevant persons in charge of Yantai Biopharmaceutical Fund of Funds attended the meeting。
The meeting pointed out,The COVID-19 epidemic is still at a serious stage,The country continues to increase support for vaccine research and development。Provincial Party Committee、The provincial government attaches great importance to the research and development and production of new coronavirus vaccines,Arrangements have been made for the research and development of the new coronavirus vaccine,Request to further accelerate the overseas clinical trials and launch process of the new coronavirus vaccine。Luye Investment seabet.com New Coronavirus Vaccine Project,Carrying our province’s hope of achieving a breakthrough in the research and development of a new coronavirus vaccine,Has both good social and economic benefits,The implementation of the project is of great significance to promoting the development of the province’s vaccine industry。
The project team of Shandong Development Investment seabet.com introduced the basic situation and investment plan of the new crown vaccine project。The person in charge of project research and development of Luye Investment seabet.com introduced the project company and Luye vaccine-related information,The vaccine has remarkable preclinical effects,Plans to conduct Phase I and II clinical trials simultaneously in Laos in December this year,It is expected to obtain national emergency use authorization in Laos and some Phase III clinical trials in the first half of 2022,At the same time,Obtained conditional marketing authorization in China。
Participating units discussed the production costs of the new coronavirus vaccine、Market space、Technical route、Listing expected、Vaccination、In-depth exchanges and discussions on project investment plans。
Contributed by:Shunhe Capital
Shandong Development Investment Holding seabet.com Co., Ltd. Copyright 2019 All rights reserved Lu ICP No. 16018610
Address: Shandong Development Building, the intersection of Haiyou Road and Xingong North Street, Lixia District, Jinan City, Shandong Province